Home Lilly cancer treatment misses key study goal
 

Keywords :   


Lilly cancer treatment misses key study goal

2013-09-27 01:07:11| Biotech - Topix.net

Shares of Eli Lilly and Co. tumbled in midday trading Thursday after the drugmaker said a potential breast cancer treatment missed its main goal in a late-stage study comparing it to a fake drug.

Tags: key study treatment goal

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
01.11Eastern North Pacific Tropical Weather Outlook
01.11Atlantic Tropical Weather Outlook
01.11CERM launches new MIS products, Mark Andy innovates and more
01.11Removing a major trade barrier: Full access to Colombia restored for U.S. beef
01.11Global BEEF Series: Leveling the playing field on quality beef
01.11Getting more out of fall and winter grazing
01.11U.S. Boston butt burger launches in Colombia
01.11All Americans have a role in keeping African swine fever out
More »